CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Legochem Biosciences Inc Company Snapshot
Legochem Biosciences Inc operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Legochem Biosciences Inc with three other companies in this sector in South Korea: Bioneer Corporation (2018 sales of 24.08 billion Korean Won [US$20.03 million] of which 100% was Biotechnology business), NanoenTek Incorporated (25.80 billion Korean Won [US$21.46 million] of which 54% was Diagnosis), and Dna Link Inc (14.88 billion Korean Won [US$12.38 million] ).

Sales Analysis. During the year ended December of 2018, sales at Legochem Biosciences Inc were 25.24 billion Korean Won (US$21.00 million). This is an increase of 14.4% versus 2017, when the company's sales were 22.06 billion Korean Won. This was the fifth consecutive year of sales increases at Legochem Biosciences Inc (and since 2013, sales have increased a total of 2,905%). Sales of Medical Development saw an increase of 20.9% in 2018, from 18.81 billion Korean Won to 22.75 billion Korean Won. Not all segments of Legochem Biosciences Inc experienced an increase in sales in 2018: sales of New Drugs R and D fell 23.2% to 2.49 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Legochem Biosciences Inc
  Stock Performance Chart for Legochem Biosciences Inc
 
  Stock Data: Recent Stock Performance:
  Current Price (8/23/2019): 43,850
(Figures in Korean Won)
1 Week 7.0%   13 Weeks -0.8%  
4 Weeks -14.0%   52 Weeks 15.4%  
 
Legochem Biosciences Inc Key Data:
  Ticker: 141080 Country: Korea (South)
  Exchanges: SEO Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 25,240,301,764
(Year Ending Jan 2019).
Employees: 80
  Currency: Korean Won Market Cap: 464,790,793,700
  Fiscal Yr Ends: December Shares Outstanding: 10,599,562
  Share Type: Common Closely Held Shares: 2,288,303
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.